INSULIN‐DEPENDENT DIABETES MELLITUS AND PRENATAL SCREENING RESULTS: CURRENT EXPERIENCE FROM A REGIONAL SCREENING PROGRAMME

From around 91 000 women having routine prenatal screening for Down's syndrome and neural tube defects between July 1992 and October 1995, 261 women were identified as having insulin‐dependent diabetes mellitus (IDDM). Alpha‐fetoprotein (AFP) and human chorionic gonadotrophin (hCG) levels were reduced in these women, with median levels of 0·89 and 0·91 multiples of the median (MOM), respectively. The IDDM patients had a median weight which was 6 kg heavier than that of non‐IDDM women. After correction for maternal weight, the AFP and hCG levels in the IDDM patients were 0·98 and 0·92 MOM, respectively. In routine practice, using results which were not weight‐corrected, the IDDM women were neither over‐ nor under‐represented in the high‐risk group for Down's syndrome, but showed a tendency to be under‐represented in the high‐risk group for neural tube defects.

[1]  J. Connor,et al.  Impact of a Regional Screening Programme Using Maternal Serum a Fetoprotein (AFP) and Human Chorionic Gonadotrophin (hCG) on the Birth Incidence of Down's Syndrome in the West of Scotland , 1994, Journal of medical screening.

[2]  J. Haddow,et al.  Human chorionic gonadotropin and unconjugated oestriol measurements in insulin‐dependent diabetic pregnant women being screened for fetal down syndrome , 1994, Prenatal diagnosis.

[3]  P. Damm,et al.  Decreased alpha‐fetoprotein in amniotic fluid and maternal serum in diabetic pregnancy , 1993, Obstetrics and gynecology.

[4]  N. Wald,et al.  Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in pregnancies with insulin‐dependent diabetes: implications for screening for Down's syndrome , 1992, British journal of obstetrics and gynaecology.

[5]  J. Connor,et al.  Prenatal screening for chromosome abnormalities using maternal serum chorionic gonadotrophin, alpha‐fetoprotein, and age , 1991, Prenatal diagnosis.

[6]  A. Baumgarten,et al.  Prospective study of an inverse relationship between maternal glycosylated hemoglobin and serum alpha-fetoprotein concentrations in pregnant women with diabetes. , 1988, American journal of obstetrics and gynecology.

[7]  E. Reece,et al.  MATERNAL SERUM ALPHA-FETOPROTEIN IN DIABETIC PREGNANCY: CORRELATION WITH BLOOD GLUCOSE CONTROL , 1987, The Lancet.

[8]  H. Cuckle,et al.  Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha‐fetoprotein level , 1987, British journal of obstetrics and gynaecology.

[9]  J. Kitzmiller,et al.  Prenatal diagnosis of neural tube defects. VIII. The importance of serum alpha-fetoprotein screening in diabetic pregnant women. , 1982, American journal of obstetrics and gynecology.

[10]  J. Minogue,et al.  Maternal serum alpha-fetoprotein levels in pregnancies complicated by diabetes: implications for screening programs. , 1990, American journal of obstetrics and gynecology.